Picard Medical, Inc. (PMI)
PMIAMEXMedical/Dental Instruments
$8.05
-0.0800 (-0.98%) today
At the close, Nov 10, 4:00 PM ET. Pre-market $8.13 +0.99%
- Market cap
- $19.99m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $2.65 to $208.00
- Average volume
- –
- Previous close
- $8.13
Earnings
next estimate $-1.50Next report Nov 13, 2026
Mar 2026
–
Jun 2026
+11.3%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $1.19m | $1.01m | $1.15m | $2.95m |
| Gross profit | -$130.0k | $411.0k | $275.0k | $616.0k |
| Operating income | -$3.49m | -$3.00m | -$4.51m | -$4.63m |
| Net income | -$10.43m | -$4.29m | -$7.62m | -$5.66m |
Last four quarters: revenue $6.30m, margin -444.3%, free cash flow –
News
8 latest- Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue EstimatesZacks · 1 day ago
- CareCloud, Inc. (CCLD) Tops Q3 Earnings and Revenue EstimatesZacks · 6 days ago
- American Well Corporation (AMWL) Reports Q3 Loss, Tops Revenue EstimatesZacks · Nov 3, 2026
- 5 After-Hours Healthcare Gainers: AMIX, PMI, TENX, KURA, NEPH RTTNews · Aug 24, 2026
- Biotech Gainers: PMI Revenue Growth, SDOT Earnings Surge, CAPR FDA Update, GRI Data Drive Gains RTTNews · Aug 24, 2026
- Picard Medical Stock Jumps 40% After Q2 Revenue Rises 39%; Loss Narrows RTTNews · Aug 24, 2026
- Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Beats Revenue EstimatesZacks · Aug 13, 2026
- Picard Announces 1-for-50 Reverse Stock Split For NYSE American Listing Compliance; Shares Plunge RTTNews · Jul 22, 2026
The company
Picard Medical, Inc. is the parent company of SynCardia Systems, LLC ('SynCardia'), the Tucson, Arizona-based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart ('STAH'), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the STAH is the most widely used and extensively studied artificial heart in the world.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- AMEX
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.